Northrop Grumman Q3 Preview: Bad News Already Priced In, Defense Is A Buy
A Seeking Alpha Q3 preview says Northrop Grumman trades near 52-week lows despite a record backlog, raised guidance, and progress on key programs. It cites strong Q2 sales and backlog growth alongside margin pressures and government-funding timing risks.
Why it matters — NOC watchers may weigh the company’s backlog and program progress against ongoing margin and funding risks ahead of Q3 earnings.